Arcutis Biotherapeutics (ARQT) announced that six-time PGA Tour winner Max Homa has joined the company’s Free to Be Me awareness campaign to help encourage the millions of Americans living with seborrheic dermatitis to speak with their healthcare providers about long-term treatment options.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARQT:
- ARQT Earnings this Week: How Will it Perform?
- Arcutis Buy Rating: Zoryve’s Strengthened Pediatric Data and Undervalued Long-Term Revenue Potential
- Arcutis Biotherapeutics announces results for Phase 2 trial of Zoryve
- Arcutis Biotherapeutics announces termination of promotion agreement with Kowa
- Arcutis announces results of survey on inflammatory skin conditions